ProfileGDS5678 / 1425894_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 1% 1% 3% 2% 2% 1% 1% 1% 1% 1% 1% 1% 1% 1% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.740561
GSM967853U87-EV human glioblastoma xenograft - Control 21.712731
GSM967854U87-EV human glioblastoma xenograft - Control 31.959813
GSM967855U87-EV human glioblastoma xenograft - Control 41.822842
GSM967856U87-EV human glioblastoma xenograft - Control 51.859612
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.71821
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.643151
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.749421
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.688941
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.706951
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.695961
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.68271
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.705721
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.686291